ITCI

Intra-Cellular Therapies Inc.
ITCI

Overview Fund Activity
Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

126 hedge funds and large institutions have $298M invested in Intra-Cellular Therapies Inc. in 2019 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 35 reducing their positions, and 25 closing their positions.

Holders
126
Holders Change
–
Holders Change %
0%
% of All Funds
2.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
42
Reduced
35
Closed
25
Calls
$15.4M
Puts
$26.2M
Net Calls
-$10.8M
Net Calls Change
-$40.6M

Top Buyers

1
WA
1
Wasatch Advisors
Utah
$30M
2
Millennium Management
2
Millennium Management
New York
$9.24M
3
ClearBridge Investments
3
ClearBridge Investments
New York
$5.87M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$4.18M
5
CS
5
Candriam SCA
Luxembourg
$6.86M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$45.8M
2
Franklin Resources
2
Franklin Resources
California
$0
3
FMBTD
3
First Midwest Bank Trust Division
Illinois
$0
4
CCI
4
Columbus Circle Investors
$0
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$1.81M
Name Market Value Shares Shares
Change 		Shares
Change %
APA
151
American Portfolios Advisors
New York
– – -250 Closed
DAM
152
DLD Asset Management
New York
– – – –
JGC
153
J. Goldman & Co
New York
– – – –
SCM
154
Sio Capital Management
New York
– – – –
BFM
155
Boothbay Fund Management
New York
– – – –
SFM
156
Sphera Funds Management
Israel
– – – –
PCM
157
Prelude Capital Management
New York
– – – –
WVP
158
Worth Venture Partners
New Jersey
– – – –
CFGS
159
Concourse Financial Group Securities
Alabama
– – – –
HT
160
HAP Trading
New York
– – – –
CM
161
Caption Management
Oklahoma
– – – –
KCM
162
Kingdon Capital Management
New York
– – – –
3 4 5 6
7